STAT5, PI3K/Akt/mTOR and MEK/Erk pathways are activated by IL-7R-mediated signaling in healthy lymphocytes and leukemia cells [9, 14, 17, 18, 24, 25, 45–47]. Here, AKT1 is linked to leukemia.